Diagnosis of alpha1-antitrypsin deficiency not just in severe COPD.

[1]  M. Miravitlles,et al.  Alpha-1 antitrypsin Pi*Z gene frequency and Pi*ZZ genotype numbers worldwide: an update , 2017, International journal of chronic obstructive pulmonary disease.

[2]  M. Miravitlles,et al.  Diagnosis of alpha-1 antitrypsin deficiency: a population-based study , 2016, International journal of chronic obstructive pulmonary disease.

[3]  M. Miravitlles,et al.  Practice and knowledge about diagnosis and treatment of alpha-1 antitrypsin deficiency in Spain and Portugal , 2016, BMC Pulmonary Medicine.

[4]  Carl Llor,et al.  Treatment patterns in COPD patients newly diagnosed in primary care. A population-based study. , 2016, Respiratory medicine.

[5]  Berend C Stoel,et al.  Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial , 2015, The Lancet.

[6]  M. Miravitlles,et al.  Actualización sobre indicaciones de búsqueda activa de casos y tratamiento con alfa-1 antitripsina por vía intravenosa en pacientes con enfermedad pulmonar obstructiva crónica asociada a déficit de alfa-1 antitripsina , 2015 .

[7]  R. Stockley,et al.  Augmentation therapy for alpha-1 antitrypsin deficiency: towards a personalised approach , 2013, Orphanet Journal of Rare Diseases.

[8]  T. Greulich,et al.  Alpha1-antitrypsin deficiency - diagnostic testing and disease awareness in Germany and Italy. , 2013, Respiratory medicine.

[9]  Gema Tirado Conde.  Factores asociados a la evolución de la función pulmonar en pacientes con déficit de alfa-1-antitripsina del registro español , 2011 .

[10]  M. Miravitlles,et al.  Factors associated with the evolution of lung function in patients with alpha-1 antitrypsin deficiency in the Spanish registry. , 2011, Archivos de bronconeumologia.

[11]  T. Welte,et al.  Diagnostic delay and clinical modifiers in alpha-1 antitrypsin deficiency , 2010, Therapeutic advances in respiratory disease.

[12]  B. Stoel,et al.  Detection of emphysema progression in alpha 1-antitrypsin deficiency using CT densitometry; Methodological advances , 2008, Respiratory research.

[13]  B C Stoel,et al.  Validation of computed tomographic lung densitometry for monitoring emphysema in α1-antitrypsin deficiency , 2006, Thorax.

[14]  A. Dirksen,et al.  American Thoracic Society/European Respiratory Society: Standards in Diagnostik und Therapie bei Patienten mit Alpha-1-Antitrypsin-Mangel , 2005 .

[15]  H Putter,et al.  Correlation between annual change in health status and computer tomography derived lung density in subjects with α1-antitrypsin deficiency , 2003, Thorax.

[16]  American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. , 2003, American journal of respiratory and critical care medicine.

[17]  R. Stockley,et al.  Longitudinal changes in physiological, radiological, and health status measurements in alpha(1)-antitrypsin deficiency and factors associated with decline. , 2001, American journal of respiratory and critical care medicine.

[18]  M. Schluchter,et al.  Feasibility of a clinical trial of augmentation therapy for alpha(1)-antitrypsin deficiency. The Alpha 1-Antitrypsin Deficiency Registry Study Group. , 2000, American journal of respiratory and critical care medicine.

[19]  M. Schluchter,et al.  Feasibility of a Clinical Trial of Augmentation Therapy for α1-Antitrypsin Deficiency , 2000 .

[20]  R. S. Sen,et al.  Survival and FEV1 decline in individuals with severe deficiency of α1-antitrypsin , 1998 .

[21]  Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study Group. , 1998, American journal of respiratory and critical care medicine.

[22]  Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting. , 1997, Bulletin of the World Health Organization.

[23]  S. Eriksson,et al.  Lung function, smoking and survival in severe alpha 1-antitrypsin deficiency, PiZZ. , 1988, Journal of clinical epidemiology.

[24]  R. Carrell,et al.  SMOKING, LUNG FUNCTION, AND α1-ANTITRYPSIN DEFICIENCY , 1985, The Lancet.